SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (2245)10/8/1997 6:58:00 PM
From: David S.   of 6136
 
Well, today a sell side analyst came out supporting my view on Thymitaq. I'll leave it to Margie to track it down. You all might want to go to your neigborhood cigar store and pick up the September issue of the journal "Cell" - which talks about an engineered virus that seeks out and destroys HIV-1 infected cells, then moves on to seek out and destroy more HIV-1 infected cells. This could be a BIG breakthrough in that we all know that many drugs can't get into certain tissues of the body where HIV resides, but a virus - that's a horse of a different color.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News